片頭痛（偏頭痛）市場の今後の見通し：トリプタンが支配する市場

Outlook for the Migraine Market With Novel Approaches Limited, Triptans Dominate

発行	Decision Resources, Inc.
出版日	2006年12月	商品コード	45801
ページ情報	英文 21 Pages
価格	こちらの商品の販売は終了いたしました。

概要
原文目次
関連レポート

当商品の販売は、2011年12月21日を持ちまして終了しました。

原文目次

Abstract

Introduction:

The treatment of migraine is an underserved, underdiagnosed market with great growth potential. Despite the current dominance of triptan therapies, the upcoming entrance of new formulations and new applications of existing treatments, as well as the introduction of new therapeutic agents, will likely substantially alter the market.

Get the Answers You Need to Shape Your Strategy:

No signifi cantly new treatment for migraine has been launched since the advent of the 5-HT1 agonists, also known as triptans. Are there other potentially effective treatments on the horizon? What effect could new treatments have on the current market? Two areas of migraine treatment exist: prophylactic, which seeks to prevent the occurrence of migraine, and abortive, which treats the symptoms of migraine after they have begun. What room for growth does each of these treatment areas contain? Which area holds the most growth potential? What are some of the roadblocks to new treatment development? GlaxoSmithKline' s fi rst patent on Imitrex is scheduled to expire in July 2007. What effect will this have on the market? What products are poised to enter the market? What is GSK doing to protect its current market dominance? What can other companies do to take advantage of this imminent patent expiration?

Scope:

Migraine background: Symptoms, triggers, etiology, and possible implicated neurotransmitters.
Patient population: Size and makeup of migraine patient populations worldwide.
Current approaches to migraine treatment: Current migraine treatments; their mechanisms of action; characteristics such as onset of action and duration of action, effi cacy, and side effects; and the factors infl uencing treatment choice.
Current market: Current migraine market, both domestic and international.
Emerging migraine therapies: New formulations of and delivery systems for existing drugs and the development of new agents. Timetable for testing and market entry for each emerging therapy.
Market outlook: The near future for markets in the United States, Europe, and Japan; factors that will affect the market; and possible future scenarios.